{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001143816.2:c.89C>T",
          "cDNA Change": {
            "transcript": "NM_001143816.2",
            "ref": "C",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_001143816.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_001143816.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "hPLD2 activity assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "hPLD2, synucleins",
        "Description": "hPLD2 activity was assayed as described. Briefly, 0.1 nM hPLD2 (1 ng) was added to assay buffer (50 mM Na-Hepes (pH 7.5), 3 mM EGTA, 80 mM KCl, 1 mM DTT, 3 mM MgCl2, 2 mM CaCl2) containing lipid vesicles (phosphatidylethanolamine (PE), phosphoinositol 4,5-bisphosphate (PI(4,5)P2), and phosphatidylcholine (PC) (Avanti Polar Lipids) molar ratio 16:1.4:1, plus 50,000-100,000 cpm [3H]phosphatidylcholine (Amersham-Pharmacia)) at a final lipid concentration of 100 μM in a total volume of 100 μl. Synucleins were added where indicated. Reactions were incubated at 37 °C for 30 minutes and then stopped with 200 μl of 10% (v/v) trichloroacetic acid and 100 μl of 10% (w/v) BSA to pre-cipitate proteins and lipids. Free [3H]choline released by hPLD2 was measured by scintillation counting."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001143816.2:c.89C>T",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "A30P inhibition was not different from wild-type."
        },
        {
          "Variant": "NM_001143816.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutant had a greater inhibitory effect compared to wild-type α-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Means ± SD for three or four separate experiments are shown."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Statistical analysis of inhibition used the General Linear Model to perform analysis of covariates (ANCOVA) to compare slopes between proteins."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Circular dichroism spectroscopy",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "hAS and the mutants DYD and S129E",
        "Description": "CD spectra were collected for hAS and the mutants DYD and S129E using a JASCO J-720 spectropolarimeter."
      },
      "Readout type": "Quantitative",
      "Readout description": [],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "hAS"
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "The a-helix content of mutants was estimated using the K2d algorithm",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}